Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): BALTARE, CARL OR;
  2. Responsible officer name: BALTARE, CARL
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (263)
Results: 1-50 | Export
  1. Akcea Therapeutics
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 2 (2019-03-01 to 2020-01-14)
    Posted: 2019-03-04
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  2. Alcon Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 2 (2019-03-01 to 2020-01-14)
    Posted: 2019-03-04
    Subject matter details: 4
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  3. Astellas Pharma Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 4 of 4 (2019-03-01 to 2020-01-14)
    Posted: 2019-03-04
    Subject matter details: 4
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  4. Alcon Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 2 (2018-09-07 to 2019-03-01)
    Posted: 2018-09-11
    Subject matter details: 4
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  5. Merck Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 9 of 9 (2018-06-25 to 2020-01-14)
    Posted: 2018-06-27
    Subject matter details: 27
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
  6. ALLERGAN CANADA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 13 of 13 (2018-04-11 to 2018-10-16)
    Posted: 2018-04-18
    Subject matter details: 12
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  7. Otsuka Canada Pharmaceutical Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2018-03-29 to 2018-10-16)
    Posted: 2018-04-03
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  8. Emblem Corporation
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2018-03-08 to 2019-02-25)
    Posted: 2018-03-13
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  9. Pharma & Biopharma Outsourcing Association
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2018-03-05 to 2019-02-25)
    Posted: 2018-03-13
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  10. Akcea Therapeutics
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 2 (2018-02-26 to 2019-03-01)
    Posted: 2018-03-08
    Subject matter details: 8
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  11. Optical Acuity Corporation
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2017-07-17 to 2018-04-02)
    Posted: 2017-07-24
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  12. ALLERGAN CANADA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 12 of 13 (2016-12-15 to 2018-04-11)
    Posted: 2016-12-20
    Subject matter details: 12
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  13. Merck Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 8 of 9 (2016-08-16 to 2018-06-25)
    Posted: 2016-09-09
    Subject matter details: 11
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  14. Astellas Pharma Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 3 of 4 (2016-07-15 to 2019-03-01)
    Posted: 2016-08-09
    Subject matter details: 4
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  15. SANOFI AVENTIS CANADA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2016-07-15 to 2019-02-25)
    Posted: 2016-07-21
    Subject matter details: 13
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  16. BAXTER CORP.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 10 of 10 (2016-07-15 to 2016-12-31)
    Posted: 2016-07-21
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
  17. Novartis Pharmaceuticals Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 12 of 12 (2016-07-15 to 2020-01-14)
    Posted: 2016-07-21
    Subject matter details: 8
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  18. LifeScan Canada Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 6 of 6 (2016-07-15 to 2019-03-19)
    Posted: 2016-07-21
    Subject matter details: 14
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  19. Otsuka Pharmaceutical Co., Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 2 (2016-07-15 to 2018-03-29)
    Posted: 2016-07-21
    Subject matter details: 3
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  20. Pediapharm Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 3 of 3 (2016-07-15 to 2018-04-02)
    Posted: 2016-07-21
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  21. Janssen Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 17 of 17 (2016-07-15 to 2018-04-02)
    Posted: 2016-07-21
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  22. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 4 of 4 (2016-07-12 to 2018-04-02)
    Posted: 2016-07-21
    Subject matter details: 3
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  23. Sigma-Tau Pharmaceuticals Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2016-03-01 to 2018-04-02)
    Posted: 2016-03-10
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  24. Innovative Medicines Canada
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 8 of 8 (2016-02-24 to 2020-01-14)
    Posted: 2016-02-26
    Subject matter details: 9
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  25. Dormer Labs Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2016-02-17 to 2018-04-02)
    Posted: 2016-03-01
    Subject matter details: 2
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  26. Duchesnay Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 2 (2015-10-01 to 2018-04-02)
    Posted: 2015-10-02
    Subject matter details: 6
    Government institutions: 3
    Communication techniques: 2
    Government funding: No
  27. Verathon Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2015-09-11 to 2018-04-02)
    Posted: 2015-09-22
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  28. Merck Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 7 of 9 (2015-08-04 to 2016-08-16)
    Posted: 2015-08-06
    Subject matter details: 11
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  29. Astellas Pharma Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 4 (2015-04-30 to 2016-07-15)
    Posted: 2015-05-01
    Subject matter details: 4
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  30. Rx&D, Canada's Research-Based Pharmaceutical Companies / Rx&D, Les compagnies de recherche pharmaceutique du Canada
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 7 of 8 (2015-04-30 to 2016-02-24)
    Posted: 2015-05-01
    Subject matter details: 9
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  31. Lundbeck Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 3 of 3 (2015-04-30 to 2015-12-04)
    Posted: 2015-05-01
    Subject matter details: 5
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  32. Novartis Pharmaceuticals Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 11 of 12 (2015-04-30 to 2016-07-15)
    Posted: 2015-05-01
    Subject matter details: 8
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  33. Sanofi Canada
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 12 of 12 (2015-04-30 to 2016-07-15)
    Posted: 2015-05-01
    Subject matter details: 13
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  34. Otsuka Pharmaceutical Co., Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 2 (2015-04-30 to 2016-07-15)
    Posted: 2015-05-01
    Subject matter details: 3
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  35. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 3 of 4 (2015-04-30 to 2016-07-12)
    Posted: 2015-05-01
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  36. ALLERGAN CANADA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 11 of 13 (2015-04-29 to 2016-12-15)
    Posted: 2015-04-29
    Subject matter details: 12
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  37. BAXTER CORP.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 9 of 10 (2015-04-29 to 2016-07-15)
    Posted: 2015-04-29
    Subject matter details: 18
    Government institutions: 12
    Communication techniques: 2
    Government funding: No
  38. BAYER INC.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 9 of 9 (2015-04-29 to 2016-08-02)
    Posted: 2015-05-01
    Subject matter details: 14
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  39. LifeScan Canada Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 5 of 6 (2015-04-29 to 2016-07-15)
    Posted: 2015-05-01
    Subject matter details: 14
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  40. Janssen Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 16 of 17 (2015-04-29 to 2016-07-15)
    Posted: 2015-05-01
    Subject matter details: 15
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  41. ALLERGAN CANADA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 10 of 13 (2015-02-04 to 2015-04-29)
    Posted: 2015-02-04
    Subject matter details: 19
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  42. Rx&D, Canada's Research-Based Pharmaceutical Companies / Rx&D, Les compagnies de recherche pharmaceutique du Canada
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 6 of 8 (2015-02-04 to 2015-04-30)
    Posted: 2015-02-04
    Subject matter details: 9
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  43. BAYER INC.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 8 of 9 (2015-02-04 to 2015-04-29)
    Posted: 2015-02-04
    Subject matter details: 24
    Government institutions: 11
    Communication techniques: 2
    Government funding: No
  44. Sanofi Canada
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 11 of 12 (2015-02-04 to 2015-04-30)
    Posted: 2015-02-04
    Subject matter details: 14
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  45. Merck Canada Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 6 of 9 (2015-02-04 to 2015-08-02)
    Posted: 2015-02-04
    Subject matter details: 11
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  46. Pediapharm Inc.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 3 (2014-11-26 to 2016-07-15)
    Posted: 2014-11-27
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  47. Red Bull Canada Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 1 of 1 (2014-07-30 to 2015-04-30)
    Posted: 2014-08-01
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  48. PURDUE PHARMA
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 2 of 4 (2014-07-21 to 2015-04-30)
    Posted: 2014-08-01
    Subject matter details: 3
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  49. Merck Frosst Canada Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 5 of 9 (2014-03-19 to 2015-02-04)
    Posted: 2014-03-19
    Subject matter details: 11
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  50. LifeScan Canada Ltd.
    Type: Consultant
    Lobbyist: CARL BALTARE, GLOBAL PUBLIC AFFAIRS
    Registration: 4 of 6 (2014-01-29 to 2015-04-29)
    Posted: 2014-01-29
    Subject matter details: 17
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
Date Modified: